Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance and metabolic syndrome, which are linked to obesity. The aim of the study was to assess if weight reduction through 12 months of lifestyle intervention and exercise would lead to improvement of steatosis.
NAFLD has been shown to be closely linked to insulin resistance and the metabolic syndrome, and there is a clear association between the current high prevalence of the metabolic syndrome and obesity [1] [2] [3] [4] . Studies have shown that, although obesity reflects an increase in adipose tissue mass and is associated with insulin resistance [5] , development of the metabolic syndrome is also influenced by the distribution of adipose tissue in the body [1, 6, 7] . Adipose tissue is regarded as an active organ in regulating metabolism by releasing adipokines that contribute to peripheral insulin resistance [8] . Body fat distribution is important for metabolic consequences, the visceral component being a significant predictor of diabetes [9, 10] . There is currently increasing evidence that distribution of fat in other areas also influences the metabolic risks associated with obesity [1, 11] .
There is evidence supporting the link between NAFLD and increased morbidity and mortality due to cardiovascular disease, regardless of risk factors that compose the metabolic syndrome [12] [13] [14] . Epidemiological studies report a lower prevalence of metabolic syndrome in individuals with higher participation in physical activity (PA), higher muscle strength, and higher cardiorespiratory fitness (CRF) [15] . Because pharmaceutical and non-pharmaceutical agents have not proven absolute efficacy and because NAFLD is often associated with obesity, diet modification and physical activity have been shown to attenuate metabolic syndrome and decrease cardiovascular mortality [16] . Church et al. were the first to suggest a similar inverse relationship between CRF and the prevalence of NAFLD [17] , and Perseghin et al. [18] demonstrated an inverse relationship between habitual PA and intrahepatic fat content. Nowadays, the discussions about the benefits of PA per se versus diet on the evolution of NAFLD are contradictory [19] . Some of the studies have shown that PA is in a reverse relation with intrahepatic fat and peripheral transaminases levels [20] . These data are crucial, as most therapeutic guidelines for persons with NAFLD suggest weight loss through lifestyle changes that include diet modifications and exercise participation [21] . However, assessment of CRF is not addressed, and precise recommendations for exercise do not exist.
The aim of the study was to assess if weight reduction obtained through 12 months of intensive lifestyle intervention and exercise regimens would lead to improvement of liver steatosis.
MATERIALS AND METHODS
In a prospective study performed between January 2010 -January 2013 in the Center of Internal Medicine of Fundeni Clinical Institute, 86 subjects (51 men and 35 women) with a BMI between 25 and 40 kg/m 2 and liver steatosis (steatotest, echo and CT) were recruited, after excluding individuals with any of the following: alcohol consumption ≥ 30 g/day in men or 20 g/day in women, presence of HBsAg or anti-HCV antibodies, fatty liver suspected to be secondary to hepatotoxic drugs, inflammatory bowel disease, celiac disease, autoimmune disease, jejunal-ileal by-pass.
Other major exclusion criteria were: inability to walk 2 blocks or 500 meters without stopping, pregnancy, intake of weight-loss medication and psychiatric problems.
All patients were assigned a caloric goal based on their starting weight (1000-1200 kcal/day if baseline weight was more than 100 kg or 1200-1500 kcal/day if baseline weight was lower than 100 kg) and a daily fat gram goal designed to produce a 25% fat diet (28-33 gr for 1000-1200 kcal diet or 33-42 gr for the 1200-1500 kcal diet).
During the program, participants were given meal plans that provided different options for meals and snacks. The use of a portion-controlled food promotes dietary adherence. Dietary compliance was assessed by using urinary ketone reagent strips (Keto-Diastix; Bayer Diagnostics). The presence of at least traces of ketones in the urine was considered to indicate net lipolysis and dietary adherence, and the test was performed each month.
The program of physical activity focused on moderate-intensity activities, with particular emphasis on walking. Other activities such as bicycling, aerobic exercises and strength were also encouraged. Participants were instructed to gradually progress to a goal of 200 min/week of moderate-intensity physical activity (achieving this goal by the end of the first 6 months). Blood was obtained in the fasting state at entry and months 6 and 12 and was tested for alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, bilirubin, albumin, total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, HOMA-IR (homeostatis model assessment), a surrogate measurement of insulin resistance as well cytokine levels (leptin, adipokine) and steatotest (Biopredictive, Paris). Liver biopsy was only accepted by 10 patients.
All participants were seen by the study principal investigator every 12 weeks and had a standard care of their liver disease. Participants were also seen weekly by a nutritionist for the first 6 months and then every two weeks from months 7 through 12.
All participants provided written informed consent prior to enrollment, and the study was approved by the Ethical Committee of Fundeni Clinical Institute.
COMPUTED TOMOGRAPHY MEASUREMENTS
All subjects underwent an abdominal CT scan before commencement and at completion of 12 months. All investigations were performed in a supine position during a single breath hold while the arms were extended over head. Contiguous 8-mm slices were then taken, including at least one image superior to and one inferior to the liver, to ensure that the entire organ was captured. The scan was performed by using a spiral sequence without medium contrast (kV = 120, mA = 250, gantry rotation = 0.75 revolutions, table speed = 48 mm/s, effective pitch = 4.5, matrix = 512 × 512, and field of view = 500 mm).
Changes in visceral and subcutaneous adipose tissue (VAT/SAT) area were determined through comparison of a single transaxial image at the level of the intervertebral space between the second and third lumbar vertebrae. These images were taken while the liver scan was performed at baseline and month 12.
The grading of hepatic steatosis was done based on hepatic-splenic attenuation difference on enhanced CT: > 5 HU: absence of significant steatosis (0-5%); -10 to 5 HU: mild to moderate steatosis (6-30%), < -10 HU: moderate to severe steatosis (> 30%). 58 
STATISTICAL ANALYSIS
Data are presented as the mean±SD if normally distributed and median (25, 75 percentile) in the case of non-gaussian distribution. Differences between groups were tested using two-tailed Student's t test or Mann Whitney U test as appropriate for two-group comparisons or using ANOVA for multiple group comparisons. Categorical variables were compared with the χ2-test. All p-values are two tailed, with p < 0.05 considered statistically significant.
Receiver operator characteristic (ROC) curve analysis was performed to identify cut-off values for parameters significantly correlated with the improvement of liver steatosis.
Variables included in the multivariate analysis were selected on the basis of the best results of univariate analyses (at a significance level of p < 0.05). Logistic regression of predictive factors used reduction of liver steatosis as dependent variable and gender, weight, BMI, ALT, GGT, HOMA, glucose, VAT, leptin and adiponectin as independent predictive variables in a single model. Results were expressed as odds ratios (Expβ) with 95% CIs.
Statistical analysis was performed using SPSS for Windows version 17.0 (SPSS, Inc., Chicago, IL).
RESULTS
86 subjects were recruited into the study and commenced the 12-month protocol. The group consisted of 51 men and 35 women and their mean (± SD) age was 47.7 ± 12.8 years. Descriptive characteristics are presented in Table 1 (Table I) . At completion of 12 months of protocol all baseline descriptive characteristics for the 86 subjects decreased significantly: body weight, BMI, waist circumference (Table II) . Baseline biochemical variables are shown in Table III . After 12 months SAT decreased more pronouncedly than VAT (Table II) .
The modification of adipocytokines was significant for leptin (7.8 ± 3.1 vs. 15.3 ± 4.8, p = 0.018) and adiponectin (9.9 ± 3.8 vs. 8.1 ± 3.3, p = 0.003) at the end of the study (Table II) . Improvement of liver steatosis, assessed by hepaticsplenic attenuation difference was significant regardless of the initial steatosis intensity (Table 3) . Factors associated with reduction of liver steatosis were weight, BMI, ALT, waist circumference, GGT, HOMA, leptin, VAT and steatotest (Table IV) .
Median values of BMI, ALT, leptin and adiponectin were chosen as cut-off values in the multivariate analysis.
Multivariate logistic regression analysis of factors related to improved liver steatosis showed: (Table V) . Data are presented as mean and standard deviation. VAT -visceral adipose tissue; HOMA -homeostatis model assessment; ALT -alanine aminotransferase; BMI -body mass index; GGT -gamma-glutamyltranspeptidase; HUhoundsfield unit
DISCUSSION
Our study presents importance due to the number of patients who adhered to this double change of life-style, due to the imagistical quantification of VAT/SAT and due to measurement of adipokines, all of which demonstrate the benefits that can be achieved without drug intervention.
Physical activity (PA) is considered to be essential for a healthy lifestyle. Although it is now a proven fact that PA has a protective role in cardiovascular and metabolic diseases, its importance in NAFLD still requires scientific evidence [22, 23] . In our present research we studied the influence of nutrition and PA on NAFLD. Regular weekly PA was associated with a lower grade of hepatic steatosis. This was associated with lower BMI, abdominal obesity, serum cholesterol, ALT, GGT and HOMA-IR. These results are consistent with other studies that have shown that PA correlates with indirect markers of NAFLD, respectively transaminase and γ-glutamyltransferase [24] or NAFLD prevalence [25] .
We compared our study with a meta-analysis of 12 other studies in the literature that assessed the efficacy of exercise in modulating hepatic steatosis [26] . Seven studies used interventions of aerobic exercise, two studies have used progressive resistance training and other 3 studies the combination of the two techniques above. In some studies, weight loss was modest (1.4 -2.2 kg), but the study period was short (4-10 weeks). All studies have shown that exercise interventions lead to a decrease of intrahepatic fat despite a minimum weight loss [26] .
Univariate analysis showed that weight, BMI and waist circumference, as well as some biological parameters (leptin and adiponectin), have the highest statistical significance in determining the risk of not responding to life-style changes, and these patients could be considered for bariatric surgery.
Regular exercise in laboratory animals reduces hepatic steatosis by decreasing the activity of lipogenic enzymes acetyl-coenzyme A carboxylase and fatty acid synthase and by reducing the activity of mitochondrial enzymes of fatty acid oxidation [27] .
As expected, steatosis and visceral adiposity were significantly correlated with severe steatosis (grade 3), being much more prevalent in patients with the largest waist circumference. The prevalence of NASH increased with increasing waist circumference, being 55% and 72% in lean and obese subjects [28] . Recently it has been proposed that a surge of insulin resistance in the adipose tissue leads to excess free fatty acids in the periphery, with ectopic accumulation and activation of nonoxidative metabolic pathways and with accumulation of toxic products that activate inflammatory pathways (IKB/NF-kB; jun N-terminal kinase). For example, pericardial adipose tissue is more closely associated with coronary artery disease than waist circumference [29] .
In patients with NAFLD, it is recommended to obtain weight loss and an improvement in blood glucose level, dyslipidemia and in cardiovascular risk through diet with or without physical activity. In our study we used an energy-restricted diet (1000-1500 kcal/day) with a certain structure, based on recommendations from the literature. Considering that saturated fat causes endoplasmatic reticulum stress, these were limited in the diet, but not less than 10% since it has been shown that a drop below 7% generates triacylglycerol increases after 6 weeks, and decreases in HDL [30] . Also, the diet contained polyunsaturated fatty acids, knowing that they decrease the risk of coronary heart disease and change the lipid composition of the hepatocyte membrane [31] .
Low-carbohydrate diets with fructose restriction and low fat diets reduce aminotransferase levels and intrahepatic fat [32] .
Several studies have shown that weight loss achieved by diet reduces liver enzymes and fatty liver, but has less significant effects on other histological components. In such a randomized trial [33] carried out on patients with NASH, in which a group was submitted to lifestyle changes (diet, exercise) versus a control group, the NAFLD activity score after 48 weeks was assessed. In the study group, a 1000-1500 kcal/day diet with 25% fat was used, according to body weight. Those who had a weight loss of over 7% showed an improvement in steatosis (p < 0.001), lobular inflammation (p < 0.03) and the NAFLD activity score (p < 0.001).
Our study underlines the known health benefits of PA; PA and diet with a low caloric goal reduces liver steatosis in parallel with visceral and subcutaneous adipose tissue. The degree of steatosis was assessed by CT and steatotest, a biochemical surrogate of liver steatosis. For Steatotest, a cut-off value of 0.30 had a 91% sensibility and 89% specificity in differentiating grade I steatosis (< 5%) from grade II steatosis (6-32%), while a cut-off of 0.70 differentiated grade II from grade III steatosis (> 32%). Lifestyle program modification induces decreases of intrahepatic fat content, topography index, HOMA-IR and sonographic aspects [34] . The association of PA with adipocytokines may explain, at least in part, the PA-NAFLD association. The adipocytokines leptin, adiponectin and resistin have all been incriminated in the development of hepatic steatosis, inflammation and fibrosis in patients with NAFLD. Serum leptin levels and resistin positively correlate with hepatic steatosis [35, 36] .
It is not surprising that leptin is a mediator in the PA-NAFLD association, because leptin serum concentrations have been shown to be reduced by long-term aerobic exercise and resistance exercise [37, 38] . Thus, exercise may improve leptin resistance, which has been shown to be associated with the pathogenesis of hepatic steatosis [39] .
As plasma leptin concentrations are tightly linked to fat mass in humans, decreases in adipose mass with weight loss coincide with decreased concentrations of circulating leptin [40] .
In hepatic steatosis, the macrophages are activated by leptin, and through NOS and NADPH oxidase, generate oxidative stress and produce THFα and MCP-1 from Kupffer cells [41] .
Adiponectin inhibit lipogenesis via sterol regulatory element-binding protein 1 (this can be induced by TNFα) and generates endoplasmic reticulum stress [42] . Adiponectin levels are low in obese patients and in those with NAFLD. In our study, weight loss and improvement of steatosis were accompanied by significant changes of serum levels of the two adipokines (leptin 15.3 ± 4.8 initially declined to 7.8 ± 3.1, p = 0.018; adiponectin 8.1 ± 3.3 vs. 9.8 ± 3.8, p = 0.003). Exercise training influences plasma levels of adiponectin and insulin sensitivity (HOMA).
These results are in line with the findings of Targher et al. [43] that hypoadiponectinemia closely correlated with NAFLD in obese individuals, which was only slightly weakened after adjustment for BMI and waist-to-hip ratio. We therefore believe that serum adiponectin level is the most sensitive reflection of hepatic steatosis. Waist circumference (WC) is the best anthropometric index for obesity and especially for visceral obesity. This is supported by the fact that VAT, but not SAT, is a predictor of diabetes in both genders [44] .
Visceral fat is the source of free fatty acids and adipokines reaching the liver through the portal vein, explaining the metabolic abnormalities associated with abdominal obesity. Therefore, the reduction of visceral obesity is a therapeutic goal in the management of obesity. In a recent study of obese patients or overweight patients with type 2 diabetes mellitus, a 12-month intensive lifestyle intervention revealed a reduction of steatosis, assessed by magnetic resonance spectroscopy in patients with weight loss of over 10% [45] .
Recently, it has become clear that VAT correlates directly with intrahepatic triglyceride (IHTG) content, and an increase in IHTG is associated with the same metabolic abnormalities linked to an increase in VAT [46, 47] . In multivariate logistic regression analysis of factors related to improved liver steatosis in our group, VAT was not significantly correlated after 12 months of lifestyle modifications. The mechanism explaining this relative reduction relates to the accumulation of fat. In early steatosis, centrolobular lipid accumulation occurs, which progressively includes the entire lobule. In severe steatosis, a significant proportion of hepatocytes can reduce their own size when the weight loss process occurs. This contrasts with changes in VAT, where adipocytes slowly and uniformly reduced their size during weight loss.
Our study measured and compared changes in liver fat, VAT and SAT over 12 months of weight loss. CT was selected because of its proven accuracy for assessing liver structure and VAT, more moderate expense and shorter acquisition time, which reduces movement artifacts and provides high accuracy and precision [48] . However, the radiation exposure for patients and the significant variation in absolute liver attenuation values obtained using different machines represent important limitations. It was not possible for us to use other imagistical investigations such as proton magnetic resonance spectroscopy or MR elastography.
Another limitation of the study is represented by the fact that the majority of patients refused liver biopsy.
Unlike other studies, we extended the dietary intervention to 12 months, to achieve an optimal balance between maximal reduction of liver fat and a reduction in VAT stores and body weight, without compromising patient compliance and acceptability.
During periods of negative energy balance, changes in fat distribution favor a reduction in visceral fat. This preferential reduction in VAT may be explained by previous observations, which suggest that visceral fat is more sensitive than SAT to lipolytic stimulation and less resistant to insulin suppression [49] .
In our study patients adhered to a double change in life-style (diet and physical activity), but we could not establish which of the two interventions 62 determined a more important improvement of liver disease. This approach was chosen in order to obtain a maximum benefit for our patients.
In summary, overweight persons who achieve significant reductions in body weight through 12 months of PA and low caloric diet can safely and effectively decrease liver fat, VAT and SAT. Even in those who had minimal weight loss ALT levels, liver steatosis, adipokines and cardiovascular risk factors improved. Liver fat does not appear to simply reflect the size of endogenous fat stores. Change in ALT, leptin and adiponectin achieved by weight reduction could predict improvement in liver steatosis. It is also unclear what kind of exercise would best improve hepatic insulin sensitivity and/or lead to the greatest loss of liver fat. Beyond these limitations, there appears to be a benefit from lifestyle modifications involving increased physical activity and weight loss to reverse fatty liver disease. 
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